> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Lists Veterinary Regenerative Medicine Studies
- URL: https://www.fdaweb.com/fda-lists-veterinary-regenerative-medicine-studies/
- Published: 2021-02-09T12:00:00.000Z
- Updated: 2026-09-14T16:45:55.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148623

FDA says it has created a [Web page](https://www.fda.gov/animal-veterinary/development-approval-process/clinical-field-studies-animal-cells-tissues-and-cell-and-tissue-based-products-actps?ref=fdaweb.com) listing clinical field studies that are investigating animal cells, tissues, and cell- and tissue-based products (ACTPs) in veterinary patients. “The Web page provides animal owners, veterinarians, researchers, and the public with information on clinical field studies that are being investigated for the use of ACTPs in veterinary patients,” an agency [statement](https://www.fda.gov/news-events/press-announcements/fda-announces-new-resource-veterinarians-and-pet-owners-interested-clinical-field-studies-animal?ref=fdaweb.com) says.

Center for Veterinary Medicine director **Steven Solomon** says the Web page is being offered as a resource “because we’ve heard from veterinarians and pet owners who are eager to take part in clinical studies and avail their patients and pets of the potential that veterinary regenerative medicine may offer. Connecting interested pet owners and their veterinary teams with relevant clinical studies also helps sponsors in generating data toward potential FDA approval.”

The statement says that generally, the agency regulates ACTPs as animal drugs if they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease in animals, or are intended to affect the structure or any function of the body of animals.